We have performed a large-scale association study, nested in the EPIC cohort, to assess the role of genetic variation of IGF1 and of the genes encoding the major IGF-I binding proteins on risk of breast cancer and on circulating levels of IGF-I and IGFBP-3. Here, IGF1 is linked to breast carcinoma.